
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6454726
[patent_doc_number] => 20100189730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'VACCINES FOR HUMAN PAPILLOMA VIRUS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/691588
[patent_app_country] => US
[patent_app_date] => 2010-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7582
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20100189730.pdf
[firstpage_image] =>[orig_patent_app_number] => 12691588
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/691588 | Vaccines for human papilloma virus and methods for using the same | Jan 20, 2010 | Issued |
Array
(
[id] => 7711102
[patent_doc_number] => 20120003720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'NUCLEIC ACID DERIVED FROM HEPATITIS C VIRUS AND EXPRESSION VECTOR, TRANSFORMED CELL, AND HEPATITIS C VIRUS PARTICLES EACH PREPARED BY USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/142227
[patent_app_country] => US
[patent_app_date] => 2009-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28128
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142227
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142227 | Nucleic acid derived from hepatitis C virus and expression vector, transformed cell, and hepatitis C virus particles each prepared by using the same | Dec 24, 2009 | Issued |
Array
(
[id] => 8701165
[patent_doc_number] => 08394384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Recombinant avian influenza vaccine and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/628085
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 21
[patent_no_of_words] => 25774
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12628085
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628085 | Recombinant avian influenza vaccine and uses thereof | Nov 29, 2009 | Issued |
Array
(
[id] => 8452804
[patent_doc_number] => 20120263751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections'
[patent_app_type] => utility
[patent_app_number] => 13/511104
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4244
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511104
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511104 | Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections | Nov 19, 2009 | Abandoned |
Array
(
[id] => 9711048
[patent_doc_number] => 08835617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 13/128143
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 78
[patent_no_of_words] => 86900
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128143
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128143 | Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same | Nov 5, 2009 | Issued |
Array
(
[id] => 6585561
[patent_doc_number] => 20100047871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'FUSION PROTEINS OF HIV REGULATORY/ACCESSORY PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/611188
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7588
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047871.pdf
[firstpage_image] =>[orig_patent_app_number] => 12611188
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/611188 | Fusion proteins of HIV regulatory/accessory proteins | Nov 2, 2009 | Issued |
Array
(
[id] => 8081041
[patent_doc_number] => 08147839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Fusion proteins of HIV regulatory/accessory proteins'
[patent_app_type] => utility
[patent_app_number] => 12/611164
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7700
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/147/08147839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12611164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/611164 | Fusion proteins of HIV regulatory/accessory proteins | Nov 2, 2009 | Issued |
Array
(
[id] => 8163387
[patent_doc_number] => 08173137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Polycistronic HIV vector constructs'
[patent_app_type] => utility
[patent_app_number] => 12/604335
[patent_app_country] => US
[patent_app_date] => 2009-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27529
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173137.pdf
[firstpage_image] =>[orig_patent_app_number] => 12604335
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/604335 | Polycistronic HIV vector constructs | Oct 21, 2009 | Issued |
Array
(
[id] => 6601562
[patent_doc_number] => 20100098724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'IMMUNOENHACER-LINKED OLIGOMERIC HIV VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/581056
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8680
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20100098724.pdf
[firstpage_image] =>[orig_patent_app_number] => 12581056
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/581056 | Immunoenhancer-linked oligomeric HIV envelope peptides | Oct 15, 2009 | Issued |
Array
(
[id] => 9427075
[patent_doc_number] => 08703145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Materials and methods for immunizing against FIV infection'
[patent_app_type] => utility
[patent_app_number] => 12/575058
[patent_app_country] => US
[patent_app_date] => 2009-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11344
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12575058
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/575058 | Materials and methods for immunizing against FIV infection | Oct 6, 2009 | Issued |
Array
(
[id] => 6349289
[patent_doc_number] => 20100021548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'USE OF MICROPARTICLES WITH ADSORBED ANTIGEN TO STIMULATE IMMUNE RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 12/573903
[patent_app_country] => US
[patent_app_date] => 2009-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8497
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021548.pdf
[firstpage_image] =>[orig_patent_app_number] => 12573903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/573903 | USE OF MICROPARTICLES WITH ADSORBED ANTIGEN TO STIMULATE IMMUNE RESPONSES | Oct 5, 2009 | Abandoned |
Array
(
[id] => 7487511
[patent_doc_number] => 20110236408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'RESPIRATORY SYNCTIAL VIRUS (RSV) SEQUENCES FOR PROTEIN EXPRESSION AND VACCINES'
[patent_app_type] => utility
[patent_app_number] => 13/121848
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 16695
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236408.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121848
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121848 | Respiratory synctial virus (RSV) sequences for protein expression and vaccines | Sep 29, 2009 | Issued |
Array
(
[id] => 8994526
[patent_doc_number] => 08518408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection'
[patent_app_type] => utility
[patent_app_number] => 13/119233
[patent_app_country] => US
[patent_app_date] => 2009-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 27494
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119233 | Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection | Sep 24, 2009 | Issued |
Array
(
[id] => 6608245
[patent_doc_number] => 20100099162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'NUCLEAR LOCALIZATION SIGNAL OF LENTIVIRAL INTEGRASE AND METHOD OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/564441
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 23057
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099162.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564441
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564441 | NUCLEAR LOCALIZATION SIGNAL OF LENTIVIRAL INTEGRASE AND METHOD OF USE THEREOF | Sep 21, 2009 | Abandoned |
Array
(
[id] => 8625295
[patent_doc_number] => 08357789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-22
[patent_title] => 'Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection'
[patent_app_type] => utility
[patent_app_number] => 12/585600
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 48
[patent_no_of_words] => 27593
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12585600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585600 | Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection | Sep 17, 2009 | Issued |
Array
(
[id] => 6087987
[patent_doc_number] => 20110217326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'METHOD FOR DIAGNOSING AND/OR TREATING TUMOR'
[patent_app_type] => utility
[patent_app_number] => 13/119645
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9171
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217326.pdf
[firstpage_image] =>[orig_patent_app_number] => 13119645
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119645 | Method for diagnosing and/or treating tumor | Sep 10, 2009 | Issued |
Array
(
[id] => 9238975
[patent_doc_number] => 08603766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence'
[patent_app_type] => utility
[patent_app_number] => 13/063400
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 19627
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063400
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063400 | Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence | Sep 10, 2009 | Issued |
Array
(
[id] => 8834321
[patent_doc_number] => 08450076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence'
[patent_app_type] => utility
[patent_app_number] => 12/558111
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 64
[patent_no_of_words] => 19652
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12558111
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/558111 | Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence | Sep 10, 2009 | Issued |
Array
(
[id] => 6498900
[patent_doc_number] => 20100209903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Method for measuring resistance of a patient HIV-2 to protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/461948
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4936
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209903.pdf
[firstpage_image] =>[orig_patent_app_number] => 12461948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/461948 | Method for measuring resistance of a patient HIV-2 to protease inhibitors | Aug 27, 2009 | Abandoned |
Array
(
[id] => 9607661
[patent_doc_number] => 08784825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC'
[patent_app_type] => utility
[patent_app_number] => 12/550166
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28723
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12550166
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550166 | Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC | Aug 27, 2009 | Issued |